- Global Pharma News & Resources

Osteoarthritis Treatment Market Global Growth Insights to 2026 – by Recent Size, Share, Regional Demand, Trends, Segmentation and Competitive Overview by CMI

Global Osteoarthritis Treatment Market

As one of the most common forms of arthritis, osteoarthritis is known to affect a majority of the population worldwide. It occurs when the protective cartilage that cushions the ends of one’s bones wears down over time. Although osteoarthritis can damage any joint in the body, the disorder mostly affects the joints of the hands, knees, hips, and spine. Also dubbed as degenerative arthritis, osteoarthritis is a chronic condition that leads to severe joint pain and stiffness of the affected body part. Other significant symptoms of the condition include decreased range of motion, joint swelling, as well as numbness of the legs and arms. The progression of osteoarthritis results in specific movement patterns, and eventually causes joint effusion, usually in the knees. The most conventional treatments for osteoarthritis include exercise regimes for reducing joint pain, pain medications, and support groups. Pain medication includes drugs, such as paracetamol, naproxen, and ibuprofen. However, in cases of severe, intolerable pain, many patients opt for joint replacement, which often ends up interfering negatively with one’s everyday activities.

Download Exclusive PDF Brochure of This Report:

Osteoarthritis as one of the most prevalent chronic diseases across the globe

In 2016, the Centers for Disease Control and Prevention (CDC) revealed that there exist more than a hundred types of arthritis, of which the most common form is osteoarthritis. Arthritis is claimed to have affected around 54.4 million adults in the U.S. during 2013-2015. According to the Arthritis Foundation, over US$ 156 billion people lost wages and medical expenses for the treatment of arthritis in 2014. It was further revealed by the same source that around 30.8 million people in the U.S. suffered from osteoarthritis in 2015. Therefore, these key stats provide direct growth opportunities to the key players involved in the global osteoarthritis treatment market.

Global Osteoarthritis Treatment Market Taxonomy

On the basis of medication type:

  • Acetaminophen
  • Non-steroidal
  • Anti-inflammatory

Based on therapies:

  • Non-pharmacological Therapy
  • Pharmacological Therapy
  • Surgical Treatment

By end users:

  • Hospitals
  • Clinics
  • Households

Tailored Information as per niche requirement:

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @

Global Osteoarthritis Treatment Market – Geographical Landscape

North America holds the largest share in the global osteoarthritis treatment market, owing to the high prevalence of arthritis in the region. The region’s growing obese population is another key aspect accelerating the market growth.

Europe holds the second-largest share of the global osteoarthritis treatment market, owing to the expansion of the region’s healthcare budget to many folds, and significant outcomes of its R&D sector. For example, a European study conducted in May 2017, developed an application of Chondroitin sulfate as an anti-inflammatory drug to help treat osteoarthritis.

Asia Pacific is expected to become the fastest-growing market in the near future, attributed to developments in the healthcare infrastructure, and the establishment of new healthcare centers for orthopedic treatment and care, especially in countries such as China, Japan, and India. For instance, the Make-in-India project launched its first bone treatment cell therapy products, Ossron and Chondron, in June 2017. Moreover, the synvisc fluid-filling procedure offering innovative regenerative cell treatments, was developed as a part of this initiative.

Cost-effective and innovative medications responsible to drive the global osteoarthritis treatment market

The emergence of new and cost effective medications for the treatment of osteoarthritis is the major growth driver of the global osteoarthritis treatment market. The Tanezumab, a drug jointly developed by Pfizer and Eli Lily, 2017, used for the chronic lower back pain relief in osteoarthritis, is awaiting FDA approval, which is expected to help millions of people. Obesity, increasing number of orthopedic injuries, crystal deposition, old age, joint injury, increasing number of pipeline drugs, and rising awareness among people are few other factors responsible for driving growth of the global osteoarthritis treatment market. However, less adoption of osteoarthritis treatment and side effects associated with of these treatments are expected to hinder the growth of the global osteoarthritis treatment market.

Got any Query? Feel free to ask us at :

Key players are focusing on R&D to establish their presence in the global osteoarthritis treatment market

The key players operating the global osteoarthritis treatment market are Johnson & Johnson Ltd., Abbott Laboratories, Pfizer, Inc., Novartis AG, Eli Lily and Co., Abiogen Pharma, Ampio Pharmaceuticals, Halyard Health, and BioDelivery Sciences International, Inc. These companies are currently concentrating on the launch of new, innovative products for the global osteoarthritis treatment market. For instance, the Halyard Health introduced the first cooled radiofrequency (RF), minimally invasive needles, and water cooled electrodes that are specifically used to alleviate chronic knee pain in osteoarthritis.

Table of Content

Global Osteoarthritis Treatment Market Research Report
Section 1: Global Osteoarthritis Treatment Industry Overview
Section 2: Global Economic Impact on Osteoarthritis Treatment Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Osteoarthritis Treatment Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Osteoarthritis Treatment Market Forecast

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 05-Mar-2021